ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY - ANVISA Registration 80464810723

Access comprehensive regulatory information for ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810723 and manufactured by MEDIPAN. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including RSR LIMITED, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80464810723
Registration Details
ANVISA Registration Number: 80464810723
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80464810723

25351258712202019

09377976000152

Company Information

MEDIPAN
Germany
PT: ALEMANHA

Dates and Status

Oct 29, 2020

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY"